Bookrunners Citigroup Global Markets and Jefferies assist with deal
By Devika Patel
Knoxville, Tenn., Feb. 28 - Ampio Pharmaceuticals, Inc. said it priced a $59.5 million public offering of stock with an $8.93 million greenshoe on Thursday.
The company will sell 8.5 million common shares $7.00 per share. The price per share reflects an 11.84% discount to the Feb. 27 closing share price of $7.94.
Citigroup Global Markets Inc. and Jefferies LLC are the joint bookrunning managers.
Settlement is expected March 5.
Proceeds will be used for working capital and general corporate purposes.
The Greenwood Village, Colo., company develops proprietary drugs for metabolic disease, eye disease, kidney disease, inflammation and CNS disease.
| Issuer: | Ampio Pharmaceuticals, Inc.
|
| Issue: | Common stock
|
| Amount: | $59.5 million
|
| Greenshoe: | $8,925,000
|
| Shares: | 8.5 million
|
| Price: | $7.00
|
| Warrants: | No
|
| Bookrunners: | Citigroup Global Markets Inc. and Jefferies LLC
|
| Pricing date: | Feb. 27
|
| Settlement date: | March 5
|
| Stock symbol: | NYSE: AMPE
|
| Stock price: | $7.94 at close Feb. 27
|
| Market capitalization: | $318.11 million
|
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.
